Go Pro
→ The Starlink of Energy (From Monument Traders Alliance) (Ad)tc pixel Free LEGN Stock Alerts

Legend Biotech (LEGN) Earnings Date, Estimates & Call Transcripts

Legend Biotech logo
$20.13 -0.14 (-0.67%)
As of 09:32 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Legend Biotech Earnings Summary

Legend Biotech released Q2 2026 earnings on August 11, 2026, reporting an EPS of $0.09, which beat analysts' consensus estimates of $0.07 by $0.02. Quarterly revenue rose 51.9% year-over-year to $387.50 million, above analyst estimates of $355.96 million. With a trailing EPS of -$0.68, Legend Biotech's earnings are expected to grow next year, from ($0.01) to $1.56 per share.

Latest Q2
Earnings Date
Aug. 11Estimated
Consensus EPS
(Aug. 11)
$0.07
Actual EPS
(Aug. 11)
$0.09 Beat By $0.02
Actual Revenue
(Aug. 11)
$387.50M

Q2 2026 Earnings Resources

Slide Deck

Legend Biotech's Q2 2026 Slide DeckFull Screen Slide Deck
Powered by Quartr
Get Legend Biotech Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Legend Biotech and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

LEGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LEGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Legend Biotech Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.03$0.00-$0.02
Q2 20262$0.11$0.22$0.17
Q3 20262$0.16$0.16$0.16
Q4 20262$0.20$0.22$0.21
FY 2026 8 $0.44 $0.60 $0.52
Q1 20271$0.17$0.17$0.17
Q2 20271$0.24$0.24$0.24
Q3 20271$0.30$0.30$0.30
Q4 20271$0.43$0.43$0.43

Legend Biotech Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026$0.07$0.09+$0.02$0.18$355.96M$387.50M
5/13/2026Q1 2026-$0.02-$0.03 -$0.01-$0.30$306.51M$305.10M
3/11/2026Q4 2025-$0.17$0.01+$0.18-$0.16$310.21M$306.30M
11/12/2025Q3 2025-$0.13-$0.11+$0.02-$0.22$277.91M$272.33M
8/11/2025Q2 2025-$0.22-$0.34 -$0.12-$0.34$237.49M$255.06M
5/13/2025Q1 2025-$0.40-$0.07+$0.33-$0.27$190.83M$195.05M
3/11/2025Q4 2024-$0.39$0.07+$0.46$0.07$179.00M$186.50M
11/12/2024Q3 2024-$0.56-$0.34+$0.22-$0.34$143.91M$160.20M

Legend Biotech Earnings - Frequently Asked Questions

Legend Biotech (NASDAQ:LEGN) last announced its quarterly earning data on Tuesday, August 11, 2026. Learn more on LEGN's earnings history.

In the previous quarter, Legend Biotech (NASDAQ:LEGN) reported $0.09 earnings per share (EPS) to beat the analysts' consensus estimate of $0.07 by $0.02. Learn more on analysts' earnings estimate vs. LEGN's actual earnings.

The conference call for Legend Biotech's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Legend Biotech's latest earnings report can be read online.
Read Transcript

Legend Biotech (NASDAQ:LEGN) has a recorded annual revenue of $1.03 billion.

Legend Biotech (NASDAQ:LEGN) has a recorded net income of -$296.80 million. LEGN has generated -$0.68 earnings per share over the last four quarters.

Legend Biotech's earnings are expected to grow from ($0.01) per share to $1.56 per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:LEGN is sourced from Fiscal.ai, with the most recent quarter reported on 8/11/2026. New results are added as companies report their earnings.
From Our Partners
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
Gold buyout deals have handed shareholders overnight gains up to 79 percent
Gold major acquisitions have repriced junior miners overnight, with past deals delivering gains from 40% to 1,...
Golden Portfolio | Sponsoredtc pixel